Request that the FDA declare that the drug product, generic ivermectin (1.87%) oral liquid is suitable for submission in an Abbreviated New Animal Drug Application (ANADA) | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

Open for Comments

FDA-2026-P-6705

Request that the FDA declare that the drug product, generic ivermectin (1.87%) oral liquid is suitable for submission in an Abbreviated New Animal Drug Application (ANADA)

Documents

Comments

Description

OPEN

Key Dates

Comment Period OpensJun 11, 2026

Documents

Type	Title	Posted	Comments	Status
Other	Suitability Petition from Argenta	Jun 11, 2026	--

Keywords

CVM

Suitability Petition

Argenta

declare that the drug product

generic ivermectin (1.87%) oral liquid

suitable for submission in an

Abbreviated New Animal Drug Application (ANADA)

OPEN

Data from Regulations.gov